Literature DB >> 17897122

Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy.

S Chalil1, B Stegemann, S A Muhyaldeen, K Khadjooi, P W Foley, R E A Smith, F Leyva.   

Abstract

OBJECTIVES: To determine the effect of a posterolateral (PL) left ventricular scar on mortality and morbidity following cardiac resynchronization therapy (CRT).
METHODS: Sixty-two patients with heart failure (age 67.3 +/- 9.6 yrs [mean +/- SD], 45 males, New York Heart Association class [NYHA] class III or IV, left ventricular ejection fraction [LVEF]= 35%, left bundle branch block, QRS > or = 120 ms) underwent late gadolinium enhancement cardiovascular magnetic resonance (LGE-CMR) for scar imaging. Patients were followed up for 741 (75-1602) days (mean [range]).
RESULTS: The presence of a PL scar emerged as an independent predictor of the composite endpoint of cardiovascular death or hospitalization for worsening heart failure (HR: 3.06 [1.63, 7.7, P < 0.0001]) as well as the endpoint of cardiovascular death (HR: 2.63 [1.39, 6.65], P = 0.0016). A transmural PL scar was the strongest predictor of these endpoints (both P < 0.0001). The symptomatic responder rate (improvement by > or =1 NYHA classes or > or =25% in 6-min walking distance) was 83% in the group with non-PL scars, but only 47% in the group with transmural PL scars (P < 0.0001). Pacing over the scar was associated with a higher mortality and morbidity than pacing outside the scar (all P < 0.05).
CONCLUSIONS: A PL scar is associated with a worse clinical outcome following CRT, particularly if it is transmural. Pacing scarred left ventricular myocardium carries a greater risk of mortality and morbidity than pacing nonscarred myocardium.

Entities:  

Mesh:

Year:  2007        PMID: 17897122     DOI: 10.1111/j.1540-8159.2007.00841.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  29 in total

Review 1.  The emerging role of cardiac resynchronization therapy in milder heart failure: are we implanting too late for response?

Authors:  Jason Bradfield; Noel G Boyle; Ravi Mandapati; Kalyanam Shivkumar
Journal:  Curr Heart Fail Rep       Date:  2012-03

Review 2.  Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy.

Authors:  Francisco Leyva; Paul W X Foley
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

Review 3.  How to improve outcomes with cardiac resynchronisation therapy: importance of lead positioning.

Authors:  Peter J Cowburn; Christophe Leclercq
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

4.  Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy.

Authors:  Evan C Adelstein; Hidekazu Tanaka; Prem Soman; Glen Miske; Stephanie C Haberman; Samir F Saba; John Gorcsan
Journal:  Eur Heart J       Date:  2010-10-22       Impact factor: 29.983

5.  The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [18F]FDG PET.

Authors:  Sebastian Lehner; Christopher Uebleis; Franziska Schüßler; Alexander Haug; Stefan Kääb; Peter Bartenstein; Serge D Van Kriekinge; Guido Germano; Heidi Estner; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-01       Impact factor: 9.236

Review 6.  Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy.

Authors:  Niti R Aggarwal; Matthew W Martinez; Bernard J Gersh; Panithaya Chareonthaitawee
Journal:  Nat Rev Cardiol       Date:  2009-11-03       Impact factor: 32.419

7.  SPECT gated blood pool phase analysis of lateral wall motion for prediction of CRT response.

Authors:  Michel Lalonde; David Birnie; Terrence D Ruddy; Robert A deKemp; Rob S B Beanlands; Richard Wassenaar; R Glenn Wells
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-09       Impact factor: 2.357

8.  Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy.

Authors:  F Leyva; P W X Foley; B Stegemann; J A Ward; L L Ng; M P Frenneaux; F Regoli; R E A Smith; A Auricchio
Journal:  Heart       Date:  2009-07-09       Impact factor: 5.994

Review 9.  Cardiac resynchronization therapy guided by cardiovascular magnetic resonance.

Authors:  Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-09       Impact factor: 5.364

Review 10.  Quantification in cardiac MRI: advances in image acquisition and processing.

Authors:  Anil K Attili; Andreas Schuster; Eike Nagel; Johan H C Reiber; Rob J van der Geest
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.